{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T15:11:42Z","timestamp":1742915502019,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":15,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071635407"},{"type":"electronic","value":"9781071635414"}],"license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-1-0716-3541-4_30","type":"book-chapter","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:27:05Z","timestamp":1701390425000},"page":"329-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantification of Mycophenolic Acid in Plasma by High Performance Liquid Chromatography-Tandem Mass Spectrometry (LC-MS\/MS)"],"prefix":"10.1007","author":[{"given":"Aja","family":"Aravamudhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse C.","family":"Seegmiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,1]]},"reference":[{"issue":"12","key":"30_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrneph.2014.172","volume":"10","author":"T Van Gelder","year":"2014","unstructured":"Van Gelder T, Van Schaik RH, Hesselink DA (2014) Pharmacogenetics and immunosuppressive drugs in solid organ transplantation. Nat Rev Nephrol 10(12):725\u2013731","journal-title":"Nat Rev Nephrol"},{"key":"30_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jchromb.2011.07.021","volume":"883","author":"J Klepacki","year":"2012","unstructured":"Klepacki J, Klawitter J, Bendrick-Peart J, Schniedewind B, Heischmann S, Shokati T, Christians U, Klawitter J (2012) A high-throughput U-HPLC\u2013MS\/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine. J Chromatogr B 883:113\u2013119","journal-title":"J Chromatogr B"},{"issue":"1","key":"30_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2215\/CJN.02860806","volume":"2","author":"H Jeong","year":"2007","unstructured":"Jeong H, Kaplan B (2007) Therapeutic monitoring of mycophenolate mofetil. Clin J Am Soc Nephrol 2(1):184\u2013191","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"30_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/clinchem\/46.3.365","volume":"46","author":"M Shipkova","year":"2000","unstructured":"Shipkova M, Schutz E, Armstrong VW, Niedmann PD, Oellerich M, Wieland E (2000) Determination of the acyl glucuronide metabolite of mycophenolic acid in human plasma by HPLC and Emit. Clin Chem 46(3):365\u2013372","journal-title":"Clin Chem"},{"issue":"3","key":"30_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1097\/00007691-200206000-00011","volume":"24","author":"M Shipkova","year":"2002","unstructured":"Shipkova M, Armstrong VW, Weber L, Niedmann PD, Wieland E, Haley J, T\u00f6nshoff B, Oellerich M, German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant R (2002) Pharmacokinetics and protein adduct formation of the pharmacologically active acyl glucuronide metabolite of mycophenolic acid in pediatric renal transplant recipients. Ther Drug Monit 24(3):390\u2013399","journal-title":"Ther Drug Monit"},{"issue":"1","key":"30_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00007691-200302000-00001","volume":"25","author":"M Shipkova","year":"2003","unstructured":"Shipkova M, Armstrong VW, Oellerich M, Wieland E (2003) Acyl glucuronide drug metabolites: toxicological and analytical implications. Ther Drug Monit 25(1):1\u201316","journal-title":"Ther Drug Monit"},{"key":"30_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10928-009-9136-6","volume":"36","author":"BCM de Winter","year":"2009","unstructured":"de Winter BCM, van Gelder T, Sombogaard F, Shaw LM, van Hest RM, Mathot RAA (2009) Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients. J Pharmacokinet Pharmacodyn 36:541\u2013564","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"6","key":"30_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","volume":"34","author":"RES Bullingham","year":"1998","unstructured":"Bullingham RES, Nicholls AJ, Kamm BR (1998) Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet 34(6):429\u2013455","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"30_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/FPC.0000000000000010","volume":"24","author":"V Lamba","year":"2014","unstructured":"Lamba V, Sangkuhl K, Sanghavi K, Fish A, Altman RB, Klein TE (2014) PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics 24(1):73","journal-title":"Pharmacogenet Genomics"},{"issue":"10","key":"30_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2165\/00003088-200241100-00005","volume":"41","author":"MS Roberts","year":"2002","unstructured":"Roberts MS, Magnusson BM, Burczynski FJ, Weiss M (2002) Enterohepatic circulation. Clin Pharmacokinet 41(10):751\u2013790","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"30_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/clpt.1988.42","volume":"43","author":"R Spector","year":"1988","unstructured":"Spector R, Park GD, Johnson GF, Vesell ES (1988) Therapeutic drug monitoring. Clin Pharmacol Ther 43(4):345\u2013353","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"30_CR12","first-page":"5","volume":"13","author":"K Budde","year":"2008","unstructured":"Budde K, Glander P (2008) Pharmacokinetic principles of immunosuppressive drugs. Ann Transplant 13(3):5\u201310","journal-title":"Ann Transplant"},{"issue":"6","key":"30_CR13","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1097\/00007691-200412000-00005","volume":"26","author":"A Pr\u00e9maud","year":"2004","unstructured":"Pr\u00e9maud A, Rousseau A, Le Meur Y, Lach\u00e2tre G, Marquet P (2004) Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther Drug Monit 26(6):609\u2013619","journal-title":"Ther Drug Monit"},{"issue":"2","key":"30_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/01.ftd.0000197092.84935.ef","volume":"28","author":"A Pr\u00e9maud","year":"2006","unstructured":"Pr\u00e9maud A, Rousseau A, Picard N, Marquet P (2006) Determination of mycophenolic acid plasma levels in renal transplant recipients co-administered sirolimus: comparison of an enzyme multiplied immunoassay technique (EMIT) and liquid chromatography\u2013tandem mass spectrometry. Ther Drug Monit 28(2):274\u2013277","journal-title":"Ther Drug Monit"},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.clinms.2017.07.001","volume":"3","author":"SD Merrigan","year":"2017","unstructured":"Merrigan SD, Kish-Trier E, Seegmiller JC, Johnson-Davis KL (2017) LC\u2013MS\/MS method for quantitation of mycophenolic acid, mycophenolic acid acyl-glucuronide, and 7-O-mycophenolic acid glucuronide in serum. Clin Mass Spectrom 3:41\u201348","journal-title":"Clin Mass Spectrom"}],"container-title":["Methods in Molecular Biology","Clinical Applications of Mass Spectrometry in Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3541-4_30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:33:14Z","timestamp":1701390794000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3541-4_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"ISBN":["9781071635407","9781071635414"],"references-count":15,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3541-4_30","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2023,12,1]]},"assertion":[{"value":"1 December 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}